James K. Weick
Impact in
- Hematology top 1%
- Acute Myeloid Leukemia Research
- Multiple Myeloma Research and Treatments
- Oncology top 2%
- Lung Cancer Research Studies
- Drug Transport and Resistance Mechanisms
Papers in
- Hematology 20
- Acute Myeloid Leukemia Research 12
- Multiple Myeloma Research and Treatments 8
- Genetics 15
- Chronic Lymphocytic Leukemia Research 8
- Glioma Diagnosis and Treatment 4
- Co-authors
- John J. CrowleyVassyl A. LonchynaRob McKennaKathy S. AlbainCary A. PresantValerie W. RuschThomas W. RiceAndrew T. Turrisi
- Journals
- Blood (9 papers)Journal of Clinical Oncology (7 papers)Cancer (6 papers)Investigational New Drugs (6 papers)International Journal of Radiation Oncology*Biology*Physics (2 papers)
- Partner nations
- United StatesSouth AfricaCanada
In The Last Decade
James K. Weick
70 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 94
- Hematology 982
- Oncology 1.3k
- Genetics 457
- Pulmonary and Respiratory Medicine 956
- Pathology and Forensic Medicine 377
Countries citing papers authored by James K. Weick
This map shows the geographic impact of James K. Weick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James K. Weick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James K. Weick more than expected).
Fields of papers citing papers by James K. Weick
This network shows the impact of papers produced by James K. Weick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James K. Weick. The network helps show where James K. Weick may publish in the future.
Co-authors
The 25 scholars most cited alongside James K. Weick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 2 | |
| 2 | 2019 | 1 | |
| 3 | 2018 | 6 | |
| 4 | 2017 | 1 | |
| 5 | 2010 | 26 | |
| 6 | 2005 | 12 | |
| 7 | 2002 | 13 | |
| 8 | Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805. Hit paper breakdown → | 1995 | 633 |
| 9 | 1994 | 49 | |
| 10 | 1994 | 3 | |
| 11 | 1993 | 23 | |
| 12 | 1993 | 9 | |
| 13 | 1992 | 25 | |
| 14 | 1992 | 58 | |
| 15 | 1991 | 72 | |
| 16 | 1991 | 27 | |
| 17 | 1990 | 50 | |
| 18 | 1989 | 2 | |
| 19 | 1988 | 112 | |
| 20 | Magnetic Resonance with Marked T2-Weighted Images: Improved Demonstration of Brain Lesions, Tumor, and Edema | 1985 | 7 |
About James K. Weick
James K. Weick is a scholar working on Hematology, Genetics, Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 71 papers that have together received 3.0k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (14 papers), Acute Myeloid Leukemia Research (12 papers), Cancer Treatment and Pharmacology (11 papers), Chronic Lymphocytic Leukemia Research (8 papers), Multiple Myeloma Research and Treatments (8 papers), Cancer therapeutics and mechanisms (7 papers), Lung Cancer Treatments and Mutations (6 papers) and Glioma Diagnosis and Treatment (4 papers). The work is most often cited by research in Hematology (982 citations), Oncology (1.3k citations), Genetics (457 citations), Pulmonary and Respiratory Medicine (956 citations) and Pathology and Forensic Medicine (377 citations). James K. Weick has collaborated with scholars based in United States, South Africa and Canada. Frequent co-authors include John J. Crowley, Vassyl A. Lonchyna, Rob McKenna, Kathy S. Albain, Cary A. Presant, Valerie W. Rusch, Thomas W. Rice, Andrew T. Turrisi, David R. Gandara and Frederick R. Appelbaum. Their work appears in journals such as Blood, Journal of Clinical Oncology, Cancer, Investigational New Drugs and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.